We demonstrated that the reduction in 5-hmC associated with a decrease in TET2 expression, which reflects the inhibition of demethylation, is involved in the development of obesity-related CRC with insulin resistance and hyperglycemia. The gene discussed is TET2; the disease is Obesity.